Related Experiment Video
Updated: May 30, 2026

In Vitro Transcribed RNA-based Luciferase Reporter Assay to Study Translation Regulation in Poxvirus-infected Cells
Published on: May 1, 2019
Translation of viral mRNA without active eIF2: the case of picornaviruses
Ewelina Welnowska1, Miguel Angel Sanz, Natalia Redondo
1Centro de Biología Molecular Severo Ochoa (CSIC-UAM), Universidad Autónoma de Madrid, Madrid, Spain.
Abstract:
Previous work by several laboratories has established that translation of picornavirus RNA requires active eIF2α for translation in cell free systems or after transfection in culture cells. Strikingly, we have found that encephalomyocarditis virus protein synthesis at late infection times is resistant to inhibitors that induce the phosphorylation of eIF2α whereas translation of encephalomyocarditis virus early during infection is blocked upon inactivation of eIF2α by phosphorylation induced by arsenite. The presence of this compound during the first hour of infection leads to a delay in the appearance of late protein synthesis in encephalomyocarditis virus-infected cells. Depletion of eIF2α also provokes a delay in the kinetics of encephalomyocarditis virus protein synthesis, whereas at late times the levels of viral translation are similar in control or eIF2α-depleted HeLa cells. Immunofluorescence analysis reveals that eIF2α, contrary to eIF4GI, does not colocalize with ribosomes or with encephalomyocarditis virus 3D polymerase. Taken together, these findings support the novel idea that eIF2 is not involved in the translation of encephalomyocarditis virus RNA during late infection. Moreover, other picornaviruses such as foot-and-mouth disease virus, mengovirus and poliovirus do not require active eIF2α when maximal viral translation is taking place. Therefore, translation of picornavirus RNA may exhibit a dual mechanism as regards the participation of eIF2. This factor would be necessary to translate the input genomic RNA, but after viral RNA replication, the mechanism of viral RNA translation switches to one independent of eIF2.
Insights
Encephalomyocarditis virus protein synthesis late in infection does not require eukaryotic initiation factor 2 alpha (eIF2α). This suggests picornavirus RNA translation uses a dual mechanism, switching to eIF2α independence after viral RNA replication.
Area of Science:
- Virology
- Molecular Biology
- Biochemistry
Background:
- Picornavirus RNA translation typically requires active eukaryotic initiation factor 2 alpha (eIF2α).
- Previous studies established eIF2α's role in cell-free systems and transfected cells.
Purpose of the Study:
- To investigate the role of eIF2α in encephalomyocarditis virus (EMCV) protein synthesis during different infection stages.
- To determine if other picornaviruses also exhibit altered eIF2α dependence during late infection.
Main Methods:
- Utilized arsenite to induce eIF2α phosphorylation and inhibit translation.
- Employed eIF2α depletion in HeLa cells.
- Performed immunofluorescence analysis to assess colocalization of eIF2α with viral components.
Main Results:
- EMCV protein synthesis late in infection was resistant to eIF2α phosphorylation inhibitors.
- Early EMCV translation was blocked by eIF2α inactivation; late translation was unaffected by eIF2α depletion.
- eIF2α did not colocalize with ribosomes or EMCV 3D polymerase during late infection.
Conclusions:
- eIF2α is not involved in EMCV RNA translation during late infection stages.
- Other picornaviruses (foot-and-mouth disease virus, mengovirus, poliovirus) also show eIF2α independence during maximal translation.
- Picornavirus RNA translation likely employs a dual mechanism, requiring eIF2α for initial RNA translation but switching to eIF2α independence post-replication.
Related Concept Videos
Leaky Scanning
Viruses with RNA Genomes
Initiation of Translation
First, the initiator tRNA must be selected from the pool of elongator tRNAs by eukaryotic initiation factor 2 (eIF2). The initiator tRNA (Met-tRNAi) has conserved sequence elements including modified bases at...
Regulated mRNA Transport
Inhibitors of Viral Protein Synthesis
Retrovirus Life Cycles

